CIA
DXCM icon

Caerus Investment Advisors’s DexCom DXCM Stock Holding History

Caerus Investment Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$221K Sell
3,525
-1,635
-32% -$114K 0.09% 221
2025
Q4 		$342K Buy
+5,160
New +$334K 0.11% 200

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Caerus Investment Advisors's DXCM Position: Q1 2026 in Review

Caerus Investment Advisors reduced its DexCom (DXCM) stake by 32% in Q1 2026, selling an estimated $114K and leaving 3,525 shares worth $221K. The position accounts for 0.09% of the portfolio, ranked #221.

Caerus Investment Advisors first reported a position in DXCM in Q4 2025 and has held it in 2 quarters since. The position peaked at $342K in Q4 2025. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Caerus Investment Advisors held 3,525 shares of DexCom worth $221K as of Q1 2026.
  • Caerus Investment Advisors sold 1,635 DexCom shares in Q1 2026, an estimated $114K.
  • DexCom made up 0.09% of Caerus Investment Advisors's portfolio in Q1 2026, its #221 holding.
  • Caerus Investment Advisors first reported a position in DexCom in Q4 2025 and has held it in 2 quarters since.
  • Caerus Investment Advisors's DexCom position peaked at $342K in Q4 2025.
  • 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Caerus Investment Advisors's 13F filing for Q1 2026, filed 1 Jun 2026.